MitoxantroneLeukemia, Basophilic, AcuteLeukemiaLeukemia, Myeloid, AcuteBasophilsLeukemia, ExperimentalLeukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidReceptors, IgELeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytarabineLeukemia Virus, MurineAntineoplastic AgentsPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsTumor Cells, CulturedAnthraquinonesLeukemia L1210Leukemia, T-CellDaunorubicinMast CellsLeukemia, Monocytic, AcuteRemission InductionDrug Resistance, NeoplasmNeoplasm ProteinsMoloney murine leukemia virusImmunoglobulin EVidarabineHistamine ReleaseATP-Binding Cassette TransportersLeukemia, Hairy CellLeukemia, B-CellDrug Resistance, MultiplePrednisoneIdarubicinLeukemia Virus, BovineLeukemia Virus, FelineCell LineEtoposideDoxorubicinHL-60 CellsReceptors, FcGene Expression Regulation, LeukemicAcute DiseaseDinitrophenolsLeukemia, Myeloid, Accelerated PhaseCell DegranulationLeukemia, Radiation-InducedCell Line, TumorBone MarrowAmsacrineMyeloid-Lymphoid Leukemia ProteinP-GlycoproteinTreatment OutcomeAutacoidsbeta-N-AcetylhexosaminidasesLeukemia P388Dose-Response Relationship, DrugLeukemia, Biphenotypic, AcuteCyclophosphamideFriend murine leukemia virusChlordanRazoxaneDrug EvaluationTopoisomerase InhibitorsMolecular Sequence DataVincristineLeukemia, Mast-CellHistidine DecarboxylaseIntercalating AgentsDrug Administration ScheduleLeukemia-Lymphoma, Adult T-CellSurvival AnalysisTopotecanLymphoma, Non-HodgkinDrug Screening Assays, AntitumorFlow CytometryBase SequenceLeukemia, Megakaryoblastic, AcuteTaxoidsPeriodic Acid-Schiff ReactionEstramustineCell SurvivalAKR murine leukemia virusFusion Proteins, bcr-ablDisease-Free SurvivalChlorambucilLeukemia, Myeloid, Chronic-PhaseRecurrenceSurvival RateCardiotoxinsCytoplasmic GranulesDNA Topoisomerases, Type IIPrecursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, MyeloidRNA, MessengerTime FactorsApoptosisProstatic NeoplasmsTopoisomerase II Inhibitors